Permanent Temp Pacemaker Electrode
Daig
FDA Clearance Information
The permanent temp pacemaker electrode was cleared by the FDA through the 510k pathway on January 16, 1981. It is manufactured by Daig and classified as a Class 3 device.
What It Is
FDA-Cleared Indications
- Temporary cardiac pacing when the heart rate or rhythm is inadequate.
- Temporary pacing support during acute cardiac care or procedures when indicated by the treating physician.
Clinical Applications
- Temporary pacing for clinically significant bradycardia.
- Temporary cardiac pacing during or after cardiac procedures when short-term pacing support is required.
- Emergency temporary pacing when an unstable heart rhythm requires electrical support.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The electrode is used with compatible temporary pacing equipment; connector and generator compatibility must be confirmed before use.
- Placement requires sterile technique and cardiac monitoring, with positioning confirmed according to the device labeling and clinical practice.
- Potential complications include bleeding, infection, vascular or cardiac injury, arrhythmia, lead displacement, and loss of capture.
- MRI safety cannot be assumed from the available FDA record; the electrode and the complete pacing system should be evaluated before MRI.
- The device is intended for temporary use, not permanent implantation. Duration depends on the clinical situation, lead performance, and the treating team's plan.
Frequently Asked Questions
What are the clinical indications for permanent temp pacemaker electrode?
The clinical indications are detailed in the FDA documentation, typically involving scenarios requiring temporary cardiac pacing.
What outcomes have been reported in clinical studies?
The systematic review highlights successful implantation and patient satisfaction with leadless pacemakers, but specific outcomes for this device are not detailed.
What complications have been reported?
Safety data from the evidence includes general risks like infection and lead dislodgement, though specific data for this device is not provided.